Stock TYCHE6 TYCHE INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Tyche Industries Limited

Equities

TYCHE6

INE443B01012

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:01:00 2024-06-27 am EDT 		5-day change 1st Jan Change
177.8 INR +0.91% Intraday chart for Tyche Industries Limited -0.11% -4.41%
May. 28 Tyche Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Feb. 12 Tyche Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Business Summary

Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.

Number of employees: 166

Sales per Business

INR in Million2022Weight2023Weight Delta
Bulk Drugs & Intermediates Products
99.9 %
620 99.5 % 753 99.9 % +21.53%
Job Work Receipts
0.1 %
3 0.5 % 1 0.1 % -79.59%

Sales per region

INR in Million2022Weight2023Weight Delta
International
59.5 %
363 58.2 % 448 59.5 % +23.67%
India
40.5 %
260 41.8 % 306 40.5 % +17.44%

Managers

Managers TitleAgeSince
Gokuraju Ganesh Kumar CEO
 Chief Executive Officer 53 98-11-13
Y. Srinivasa Rao DFI
 Director of Finance/CFO - 17-05-29
Pradosh Ranjan Jena CMP
 Compliance Officer - 23-07-31

Members of the board

Members of the board TitleAgeSince
Gokuraju Ganesh Kumar CEO
 Chief Executive Officer 53 98-11-13
P. Vijaya Lakshmi BRD
 Director/Board Member 39 14-08-10
Panchakarla Sai Sudhakar BRD
 Director/Board Member 49 19-03-24
Sandeep Gokaraju BRD
 Director/Board Member 41 20-08-23
Venkataraju Gupta Kollepalli BRD
 Director/Board Member 56 21-02-11
Srinivas Gelli BRD
 Director/Board Member 55 23-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,235,600 2,888,833 ( 28.22 %) 0 28.22 %

Company contact information

Tyche Industries Ltd.

H. No. C21/A, Road No. 9 Film Nagar

500096, Hyderabad

+

http://www.tycheindustries.net
address Tyche Industries Limited(TYCHE6)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
TYCHE INDUSTRIES LIMITED Stock Tyche Industries Limited
-4.41% 21.6M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.87% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.94% 333B
ABBVIE INC. Stock AbbVie Inc.
+8.39% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 225B
NOVARTIS AG Stock Novartis AG
+12.47% 218B
AMGEN INC. Stock Amgen Inc.
+8.92% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TYCHE6 Stock
  4. Company Tyche Industries Limited